SCHEMBL10126533

SCHEMBL10126533

CSc1nc(Cl)c(C(N)=O)c(Nc2ccc(S(C)(=O)=O)c(C)c2)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CA7 P43166 2/20 0.44
ALDH1A1 P00352 1/20 0.43
CA13 Q8N1Q1 1/20 0.43
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.37
PPARG P37231 2/20 0.37
MAPT P10636 1/20 0.36
POLB P06746 1/20 0.36
GRM4 Q14833 1/20 0.34
GAA P10253 1/20 0.34
HPGD P15428 1/20 0.34
PDE4B Q07343 1/20 0.34
CDK1 P06493 1/20 0.34
CDK2 P24941 1/20 0.34
KDR P35968 1/20 0.34
KDM4E B2RXH2 1/20 0.34
MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL328295 0.92 CA1 (0.44) CA1CA2CA7CA13MEN1
SCHEMBL10126528 0.85 MAPT (0.43) CA1CA2CA7ALDH1A1L3MBTL1
SCHEMBL10127026 0.84 CA1 (0.56) CA1CA2CA7CA13MEN1
SCHEMBL282561 0.83 ALK (0.46) CA1CA2CA7ALDH1A1CA13
SCHEMBL10126589 0.81 PPARG (0.41) CA1CA2CA7ALDH1A1CA13
SCHEMBL10126491 0.81 CA1 (0.41) CA1CA2CA7ALDH1A1CA13
SCHEMBL10156674 0.80 CA1 (0.40) CA1CA2CA7CA13MAPT
SCHEMBL17069444 0.80 LMNA (0.47) PPARGMAPTKDR
SCHEMBL10127090 0.79 CA1 (0.48) CA1CA2CA7ALDH1A1CA13
SCHEMBL10126531 0.79 ALDH1A1 (0.42) ALDH1A1MEN1KMT2AL3MBTL1PDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9487491-B2 Diamino heterocyclic carboxamide compound ASTELLAS PHARMA INC. (JP) 2016-11-08 US disclosed
US-8969336-B2 Diamino heterocyclic carboxamide compound ASTELLAS PHARMA INC. (JP) 2015-03-03 US disclosed
US-20140371196-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND ASTELLAS PHARMA INC. (JP) 2014-12-18 US disclosed
US-20120040968-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND WATERS TECHNOLOGIES CORPORATION (US) 2012-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140371196-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND EML4, ALK, ERBB4 CA1 2814/4885CA2 1945/4885CA7 2233/4885
US-20120040968-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND EML4, ALK, ERBB4 CA1 2814/4885CA2 1945/4885CA7 2233/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.